18α-甘草酸的合成工艺研究

李宇兴 ,  马学燕 ,  赵轲 ,  赵佳星

中国药科大学学报 ›› 2026, Vol. 57 ›› Issue (3) : 288 -294.

PDF (1041KB)
中国药科大学学报 ›› 2026, Vol. 57 ›› Issue (3) : 288 -294. DOI: 10.11665/j.issn.1000−5048.2025081501
论文

18α-甘草酸的合成工艺研究

作者信息 +

Study on synthetic process of 18α-glycyrrhizic acid

Author information +
文章历史 +
PDF (1065K)

摘要

优化 18α-甘草酸的合成工艺。以 18β-甘草酸单铵盐为起始原料,经异构化、酯化和水解反应得到目标化合物 18α-甘草酸。目标化合物及关键中间体的结构经1H NMR、13C NMR 和 HRMS 确证,目标化合物的总收率为 9.43%,纯度为 99.23%,杂质 A 的含量为 0.17%。优化后的工艺显著提高了异构化转化率,降低了有关物质的生成,简化了纯化工序,更有利于工业化生产和成本控制。

Abstract

In this study, the synthetic process of 18α-glycyrrhizic acid was optimized. Using 18β-glycyrrhizic acid monoammonium salt as the starting material, the target compound 18α-glycyrrhizic acid was obtained through isomerization, esterification, and hydrolysis, with a total yield of 9.43%, purity of 99.23% and key impurity A of 0.17% (HPLC). The optimized process significantly improved the isomerization conversion rate, reduced the formation of related substances, simplified the purification steps, and enhanced both industrial scalability and cost efficiency.

关键词

18α-甘草酸 / 合成 / 工艺优化

Key words

18α-glycyrrhizic acid / synthesis / process optimization

引用本文

引用格式 ▾
李宇兴,马学燕,赵轲,赵佳星. 18α-甘草酸的合成工艺研究[J]. 中国药科大学学报, 2026, 57(3): 288-294 DOI:10.11665/j.issn.1000−5048.2025081501

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Lin YD, Fang Y, Yang BC. Analysis of contraindications for liquorice disease and syndrome[J]. China J Tradit Chin Med Pharm(中华中医药杂志), 2014, 29(8): 2521-2524.

[2]

Bakr AF, Shao P, Farag MA. Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review[J]. Phytomedicine, 2022, 99: 153999.

[3]

Ding N, Gao XL. Recent developments on study of hepatoprotective activities of 18α—glycyrrhizic acid[J]. AntiInfect Pharm(抗感染药学), 2011, 8(01): 11-13.

[4]

Han ZJ, Xu MJ, Liu L, et al. Pharmacological effects and clinical application progress of magnesium isoglycyrrhizinate[J]. Pharm Clin Res(药学与临床研究), 2023, 31(3): 238-242.

[5]

Ma SW, Liu CH, Liu XY, et al. Chinese guideline for diagnosis and management of drug—induced liver injury(2023 version)[J]. Chin J Gastroenterol(胃肠病学), 2023, 28(7): 397-431.

[6]

Wu XM, Wang P. Magnesium isoplycyrrhetate and its preparing process and usage: CN1169826C[P]. 2004—10—06.

[7]

Jing L, Zhang Z. Method for preparing diammonium glycyrhetate: CN1743338A[P]. 2006—03—08

[8]

Miyashita A, Okada K, Kuramoto T. 18 alpha—Glycyrrhizinic acid and salt thereof: US4393200A[P]. 1983—07—12.

[9]

Liu MJ, Lu SH, Hu YX, et al. Determination of related substances in magnesium isoglycyrrhizinate by HPLC[J]. Chin J New Drugs(中国新药杂志), 2020, 29(4): 464-469.

[10]

Liu XQ, Wu SP, Zheng X, et al. Study on the quality standard of compound ammonium glycyrrhizinate injection[J]. Drug Stand China(中国药品标准), 2009, 10(3): 192-196.

[11]

Yu SB, Yang QL, Qi SY, et al. A method for purifying glycyrrhizic acid: CN115772199B[P]. 2024—12—24.

[12]

Yang QL, Zou JF, Wu DR, et al. A method for synthesizing magnesium isoglycyrrhizinate and its application: CN116693594A[P]. 2023—09—05.

[13]

Weng MJ, Zhou Q. Cis—glycyrrhizic acid isomerization method: CN110818765A[P]. 2020—02—21.

[14]

Jiang H, Yu SB; Lv Jia. A method for isomerizing glycyrrhizic acid and a method for preparing magnesium isoglycyrrhizinate: CN117567545A[P]. 2024—02—20.

[15]

Weng MJ, Wang ZY. Methyl isoglycyrrhizinate refining method: CN107488207A[P]. 2017—12—19.

[16]

Lu DQ, Chen L, Wang XX, et al. Method for preparing isoglycyrrhizinate through catalytic splitting: CN109486896A[P]. 2019—03—19.

[17]

Jitrangsri K, Kamata K, Akiba M, et al. Is 18α—glycyrrhizin a real natural product? Improved preparation of 18α—glycyrrhizin from 18β—glycyrrhizin as a positive standard for HPLC analysis of licorice extracts[J]. J Nat Med, 2022, 76(2): 367-378.

[18]

Xing DX, Zhang L, Li WQ, et al. Synthesis of 18α—glycyrrhizic acid by yeast cells[J]. CIESC J(化工学报), 2024, 75(9): 3266-3276.

[19]

Kononova PA, Selyutina OY, Polyakov NE. The interaction of the transmembrane domain of SARS—CoV—2 E—protein with glycyrrhizic acid in lipid bilayer[J]. Membranes, 2023, 13(5): 505.

基金资助

甘肃省科技专员专项(25CXGA029)

国家自然科学基金项目(82560852)

AI Summary AI Mindmap
PDF (1041KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/